Niagen Bioscience Inc (NAGE)
$2.58-1.90%Close
SELLCRISIS · day 9
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $205M
- Beta
- 2.02
- P/E (TTM)
- 13.29
- Short % float
- 7.38%
- Days to cover
- 9.9
- SI change
- -3.1%
- 1W
- -4.09%
- 1M
- -15.13%
- vs SPY 1W
- -3.95%
- vs SPY 1M
- -17.64%
Industry peers
FMP comparable companies · ranked by market cap
- KALVKalVista Pharmaceuticals, Inc.$1.4B$27.00
- VTYXVentyx Biosciences, Inc.$1.0B$14.00
- CRVSSELLCorvus Pharmaceuticals, Inc.$888MCRISISQ 12$10.56-6.37%
- RIGLBUYRigel Pharmaceuticals, Inc.$853MBULLQ 9$46.11-3.42%
- OLMASELLOlema Pharmaceuticals, Inc.$692MCRISISQ -1$7.92-4.62%
- ZVRASELLZevra Therapeutics, Inc.$634MCRISISQ -8$10.73-8.22%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 37
- VALUE
- 42
- GROWTH
- 64
- GARP
- 15
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC12.3%
REV YoY-
ROE20.5%
EPS YoY-
ROA15.0%
GROSS64
OP7
NET12
[VALUATION]
P/E TTM13.29
P/E FWD23.75
SECTOR PE20.34
INDUSTRY PE13.84
P/B2.48
P/FCF-
EV/EBITDA7.70
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E2.82
ALTMAN Z-
CURR RATIO6.50
ND/EBITDA-
BETA2.02
Company news
FAQ
- What is LOPJLB’s current signal on NAGE?
- LOPJLB’s latest quantitative signal on Niagen Bioscience Inc (NAGE) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is NAGE in?
- Niagen Bioscience Inc (NAGE) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Niagen Bioscience Inc (NAGE) do?
- Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regul…